# A Study of Chemoradiation Plus Pembrolizumab for Locally Advanced Laryngeal Squamous Cell Carcinoma

> **NCT02759575** · PHASE1,PHASE2 · COMPLETED · sponsor: **Vinita Takiar** · enrollment: 9 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** Pembrolizumab
- **RADIATION:** Radiation Therapy
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT02759575
- **Lead sponsor:** Vinita Takiar
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2019-01-24
- **Final completion:** 2021-02
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2021-03-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02759575

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02759575, "A Study of Chemoradiation Plus Pembrolizumab for Locally Advanced Laryngeal Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02759575. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*